Derivative Financial Instruments at Fair Value |
The following table presents assets and liabilities representing the fair value of our most significant derivative financial instruments. The fair values of the derivatives reflect the change in the market value of the derivative from the date of the trade execution and do not consider the offsetting underlying hedged item. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Expiring at various dates through: | | Total USD Equivalent Notional Amount | | As of June 30, 2021 | | Assets | | Liabilities | Other Current Assets | | | | Other Current Liabilities | | Other Long-Term Liabilities | Derivatives designated as hedging instruments | | | | | | | | | | | Cash flow hedges: | | | | | | | | | | | | | | | | | | | | | | | | Currency hedges: | | | | | | | | | | | | Future USD sales/purchases of Canadian, Chinese, European, South Korean, Swiss, and UK subsidiaries | Dec 2022 | | $ | 161.2 | | | $ | 4.0 | | | | | $ | .2 | | | $ | .2 | | Future DKK sales of Polish subsidiary | Dec 2022 | | 17.5 | | | — | | | | | .1 | | | — | | | | | | | | | | | | | | Future EUR sales of Chinese, Swiss, and UK subsidiaries | Dec 2022 | | 56.7 | | | 1.4 | | | | | — | | | — | | Future MXN purchases of a USD subsidiary | Sep 2022 | | 9.4 | | | .6 | | | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total cash flow hedges | | | | | 6.0 | | | | | .3 | | | .2 | | Fair value hedges: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Intercompany and third-party receivables and payables exposed to multiple currencies (DKK, EUR, MXN, USD, and ZAR) in various countries (CAD, CNY, EUR, PLN, and USD) | Oct 2021 | | 137.8 | | | .5 | | | | | .2 | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | | Non-deliverable hedges (EUR and USD) exposed to the CNY | Mar 2022 | | 14.2 | | | .4 | | | | | — | | | — | | USD receivable on a CAD subsidiary | Jul 2021 | | 18.0 | | | .1 | | | | | — | | | — | | GBP sales and receivables on a EUR subsidiary | Dec 2021 | | 22.1 | | | .1 | | | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total derivatives not designated as hedging instruments | | | | | .6 | | | | | — | | | — | | Total derivatives | | | | | $ | 7.1 | | | | | $ | .5 | | | $ | .2 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Expiring at various dates through: | | Total USD Equivalent Notional Amount | | As of December 31, 2020 | | Assets | | Liabilities | Other Current Assets | | Sundry | | Other Current Liabilities | | Other Long-Term Liabilities | Derivatives designated as hedging instruments | Cash flow hedges: | | | | | | | | | | | | Currency hedges: | | | | | | | | | | | | Future USD sales/purchases of Canadian, Chinese, European, South Korean, Swiss and UK subsidiaries | Jun 2022 | | $ | 149.3 | | | $ | 6.3 | | | $ | .1 | | | $ | 1.2 | | | $ | .1 | | | | | | | | | | | | | | Future MXN purchases of a USD subsidiary | Jun 2022 | | 9.3 | | .7 | | | .1 | | | — | | | — | | | | | | | | | | | | | | Future DKK sales of a Polish subsidiary | Jun 2022 | | 18.5 | | — | | | — | | | .5 | | | .1 | | Future EUR sales of Chinese and UK subsidiaries | Jun 2022 | | 46.7 | | | — | | | — | | | .2 | | | .1 | | Total cash flow hedges | | | | | 7.0 | | | .2 | | | 1.9 | | | .3 | | Fair value hedges: | | | | | | | | | | | | Intercompany and third-party receivables and payables exposed to multiple currencies (DKK, EUR, MXN, USD and ZAR) in various countries (CAD, CNY, GBP, PLN and USD) | Jun 2021 | | 49.5 | | | .3 | | | — | | | .1 | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | | Non-deliverable hedges (EUR and USD) exposed to the CNY | Dec 2021 | | 14.4 | | | .4 | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | Hedge of USD receivable on a CAD subsidiary | Jan 2021 | | 18.5 | | | — | | | — | | | .2 | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | Total derivatives not designated as hedging instruments | | | | | .4 | | | — | | | .2 | | | — | | Total derivatives | | | | | $ | 7.7 | | | $ | .2 | | | $ | 2.2 | | | $ | .3 | |
|
Pre-Tax (Gains) Losses of Hedging Activities |
The following table sets forth the pretax (gains) losses for our hedging activities for the periods presented. This schedule includes reclassifications (including impact of underlying transactions probable of not occurring) from accumulated other comprehensive income (see Note 12) as well as derivative settlements recorded directly to income or expense. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Caption in Consolidated Condensed Statements of Operations | | Amount of (Gain) Loss Recorded in Income Six Months Ended June 30, | | Amount of (Gain) Loss Recorded in Income Three Months Ended June 30, | 2021 | | 2020 | | 2021 | | 2020 | Derivatives designated as hedging instruments | | | | | | | | | | | | | | | | | | | | Interest rate cash flow hedges | Interest expense | | $ | 2.3 | | | $ | 2.2 | | | $ | 1.2 | | | $ | 1.1 | | Currency cash flow hedges | Net trade sales | | (4.9) | | | 1.2 | | | (2.7) | | | .6 | | Currency cash flow hedges | Cost of goods sold | | .3 | | | (.3) | | | .1 | | | — | | | | | | | | | | | | Total cash flow hedges | | | (2.3) | | | 3.1 | | | (1.4) | | | 1.7 | | Fair value hedges | Other (income) expense, net | | (4.0) | | | 2.5 | | | (3.5) | | | (2.5) | | | | | | | | | | | | Derivatives not designated as hedging instruments | Other (income) expense, net | | (.2) | | | (.2) | | | (.5) | | | 1.1 | | | | | | | | | | | | Total derivative instruments | | | $ | (6.5) | | | $ | 5.4 | | | $ | (5.4) | | | $ | .3 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|